Paradigm-shifting, practice-changing clinical trials in #Urology: The next generation trial: assessing 18F-PSMA-1007 PET and MRI in primary staging of #ProstateCancer patients. Presented by @NikMookerji@UAlberta. #AUA24 coverage by @zklaassen_md > https://t.co/9aYhXrW1pc
We found that ERBT could reduce the 1-year recurrence rate from 38.1% to 28.5% (p=0.007). Upon subgroup analysis, patients with 1-3cm tumour, single tumour, Ta disease, or intermediate-risk NMIBC had a significant benefit from ERBT. 💫 #UroSoMe (3/n)
Even in the 3rd edition of our Robotic Surgery Course in @USLUmbria2 10 experienced surgeons had the opportunity to appreciate our experience and share their own.Tnx to all my colleagues, tnx to our chief Dr Luigi Mearini and @VivacquaCarlo for the success of this wonderful event
Even this year the #endourology course organized by @USLUmbria2 has come to an end. Interesting discussions of clinical cases and challenging live surgery sessions to improving knowledge and understanding! Thx to @VivacquaCarlo and @GoumasUrologia as mentor!
Appena concluso il III corso teorico pratico di endourologia presso la usl Umbria 2. Un appuntamento ormai imperdibile…grazie all’amico Ioannis Goumas…ci vediamo nel 2025
🔷AIFA si illumina di blu per contrastare l’ #antibioticoresistenza
🗓️Settimana Mondiale per uso consapevole #antibiotici
💊 L'uso scorretto mette a rischio la tua salute e quella degli altri. Non prenderli di tua iniziativa, ma sempre secondo le prescrizioni del tuo medico
#EAAD